Rheumatoid arthritis (RA) is polygenic autoimmune disease with unclear etiology. MicroRNAs (miRNAs) play a critical role in the pathogenesis of RA. The objective of this study was to evaluate the role of miR-146a in patients with RA receiving Tripterygium wilfordii Hook F (TwHF) treatment.In total, 69 patients with RA and 69 healthy controls (HC) were included in the study, and patients with RA received TwHF treatment for 24 weeks. Blood samples were collected from RA patients and HC, and peripheral blood mononuclear cells (PBMCs) were isolated. Expression of miR-146a was analyzed in RA patients (baseline, 12 weeks and 24 weeks) and HC.Circulating miR-146a expression was markedly increased in patients with RA compared with healthy controls (P < .001), ROC analysis of miR-146a for diagnosis for RA showed that the AUC was 0.908 (95% CI: 0.862–0.955) with a sensitivity of 87.0% and a specificity of 82.6% at best cutoff. And miR-146a expression was positively associated with the DAS28 score and CRP level (P = .002 and P = .019). Moreover, miR-146a expression was markedly reduced after TwHF therapy (P < .001), and baseline miR-146a level was observed to present an increased tendency in responders compared with non-responders at 24 weeks (P = .066).Our study presented that circulating miR-146a level was correlated with risk and disease activity of RA patients by TwHF treatment, which could strikingly decrease expression of miR-146a in RA patients, and miR-146a may have a value in predicting clinical response of TwHF treatment. It indicates that circulating miR-146a plays a prominent role in RA patients treated by TwHF.
Objective: This study aims to describe the technique and feasibility of laparoscopic submucosal tunneling ureteroneocystostomy in combination with psoas hitch to restore urinary tract continuity in patients showing medium-length distal ureteral defects. Materials and Methods: From January 2012 to April 2016, a total of 13 patients (4 males and 9 females) with a mean age of 37 years were performed with the laparoscopic operation of ureteral submucosal tunneling reimplantation combined with psoas hitch. The mean defective length was 5.5 cm (range 4-8 cm). The etiologies included ureteral strictures secondary to endoscopic laser lithotripsy in 2 patients, previous gynecological surgeries in 4, infiltrative ureteral endometriosis in 3, as well as ureteral strictures without obvious causes in the remaining 4. Results: The operations were successfully performed in all patients. The mean operating time was 179 min (range 150-230 min). The mean estimated blood loss was 32 mL (range 15-80 mL). The mean drainage time was 5.8 days (range 4-8 days). No major complications occurred during the perioperative period. The mean follow-up time was 25 months. All patients experienced symptomatic relief and showed good urine drainage. Conclusion: Extravesical submucosal tunneling ureteroneocystostomy combined with psoas hitch under laparoscopy is a feasible and effective option for medium-length distal ureteral defects in selected patients.
Background: When it comes to the treatment of aplastic anemia fever, the Guidelines for Aplastic Anemia regards Anti-thymocyte globulin (ATG) combined with eltrombopag as the standard immunosuppressive treatment plan, and ATG is the main mode to treat severe aplastic anemia. A large number of prospective studies and clinical trials have confirmed the clinical application value of eltrombopag in aplastic anemia.Although ATG combined with eltrombopag brings satisfactory treatment results, the safety of long-term use is still unclear. Therefore, more clinical trial studies are needed to verify its safety.Methods: Literature in the Chinese and English medical databases was searched using the following search terms: "Antithymocyte globulin", "severed aplastic anemia" and "eltrombopag". Patients in the experimental group were administered ATG combined with eltrombopag and patients in the control group received ATG treatment alone. Rev Man5.3 software was used for meta-analysis.Results: A total of 16 references were included in this meta-analysis. Heterogeneity tests examining total effective rate demonstrated that Chi 2 =4.48, df =15, I 2 =0%<50%, and P=1.00>0.01. The effective rate of the experimental group was higher than that of the control group, with odds ratio (OR) =1.90 and 95% confidence interval (CI) 1.35 to 2.68 (Z=3.70, P=0.0002). The heterogeneity test results of the survival rate within 2 years were Chi 2 =3.09, df =7, I 2 =0%<50%, and P=0.88>0.01. The survival rate of the experimental group was higher than that of the control group, with OR =2.54, and 95% CI: 1.58 to 4.09 (Z=3.84, P=0.0001).The heterogeneity test results of the mortality rate were Chi 2 =3.49, df =6, I 2 =0%<50%, and P=0.75>0.01.The mortality rate of the experimental group was lower than that of the control group, with OR =0.48 and 95% CI: 0.33 to 0.70 (Z=3.84, P=0.0001). The heterogeneity test results of the occurrence of side effects were Chi 2 =0.12, df =3, I 2 =0%<50%, P=0.99>0.01. The incidence of side effects in the experimental group was lower than that in the control group, with OR =0.74, 95% CI: 0.48 to 1.17 (Z=1.29, P=0.20).
Novel near-infrared (NIR) phosphors are in demand for light-emitting diode (LED) devices to extend their suitability for new applications and, in turn, support the sustainable and healthy development of the LED industry. The Cr3+ has been used as an activator in the development of new NIR phosphors. However, one main obstacle for the Cr3+-activated phosphors is the low luminescence efficiency due to the spin-forbidden d-d transition of Cr3+. The rare-earth (RE) huntite minerals that crystallize in the form of REM3(BO3)4 (M = Al, Sc, Cr, Fe, Ga) have a large family of members, including the rare-earth scandium borates of RESc3(BO3)4. Interestingly, in our research, we found that the luminescence efficiency of Cr3+ in the CeSc3(BO3)4 host, whose quantum yield was measured at 56%, is several times higher than that in GdSc3(BO3)4, TbSc3(BO3)4, and LuSc3(BO3)4 hosts. Hereby, the energy conversion and transfer in the luminescence of CeSc3(BO3)4:Cr3+ phosphor were examined. The Stokes shift of electron energy conversion within the Cr3+ 4T2g level for the emission at 818 nm and excitation at 625 nm in CeSc3(BO3)4 host was evaluated to be 3775.1 cm−1, and the super-large splitting energy of the 2F5/2 and 2F72 sub-states of the Ce3+ 4f1 state, about 3000 cm−1, was found in CeSc3(BO3)4 host. The typical electronic thermal vibration peaks were observed in the excitation spectra of CeSc3(BO3)4:Cr3+. On this basis, the smallest phonon energy, around 347.7 cm−1, of the CeSc3(BO3)4 host was estimated. Finally, the energy transfer that is responsible for the far higher photoluminescence of Cr3+ in CeSc3(BO3)4 than in other hosts was proven through the way of Ce3+ emission and Cr3+ reabsorption.
No abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.